Multimodality therapy of esophageal cancer: An update Journal Article


Author: Kelsen, D. P.
Article Title: Multimodality therapy of esophageal cancer: An update
Abstract: The incidence of adenocarcinoma of the esophagus is rapidly increasing in Western countries, particularly in Caucasian men. Both squamous cell carcinoma and adenocarcinoma are equally virulent tumors. In the absence of effective prevention and screening programs, most Western patients are found to have locally advanced or metastatic disease at the time of diagnosis. The outcome with regional therapy alone (either surgery or radiation) is poor. Multimodality therapy - treatment plans which include both systemic and regional treatments - is the focus of intense study. This review will summarize the current status of several different approaches that have the goal of increasing the cure rate in patients with newly diagnosed esophageal cancers.
Keywords: treatment outcome; treatment failure; review; squamous cell carcinoma; multimodality cancer therapy; antineoplastic agents; paclitaxel; preoperative care; combined modality therapy; antineoplastic agent; cancer incidence; adenocarcinoma; tumor markers, biological; camptothecin; cancer screening; cancer invasion; esophagus cancer; chemoradiation; esophageal neoplasms; esophageal cancer; cisplatin derivative; humans; human; male; priority journal; multimortality therapy
Journal Title: The Cancer Journal
Volume: 6
Issue: Suppl. 2
ISSN: 1528-9117
Publisher: Lippincott Williams & Wilkins  
Date Published: 2000-04-01
Start Page: S177
End Page: S181
Language: English
PUBMED: 10803833
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 18 November 2015 -- Source: Scopus
Citation Impact
MSK Authors
  1. David P Kelsen
    537 Kelsen
Related MSK Work